![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
zu Natrup, Christian Meyer; Tscherne, Alina; Dahlke, Christine; Ciurkiewicz, Malgorzata; Shin, Dai-Lun; Fathi, Anahita; Rohde, Cornelius; Kalodimou, Georgia; Halwe, Sandro; Limpinsel, Leonard; Schwarz, Jan H.; Klug, Martha; Esen, Meral; Schneiderhan-Marra, Nicole; Dulovic, Alex; Kupke, Alexandra; Brosinski, Katrin; Clever, Sabrina; Schuenemann, Lisa-Marie; Beythien, Georg; Armando, Federico; Mayer, Leonie; Weskamm, Marie L.; Jany, Sylvia; Freudenstein, Astrid; Tuchel, Tamara; Baumgaertner, Wolfgang; Kremsner, Peter; Fendel, Rolf; Addo, Marylyn M.; Becker, Stephan; Sutter, Gerd und Volz, Asisa
(2022):
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity.
In: Journal of Clinical Investigation, Bd. 132, Nr. 24, e159895
2020
Kreer, Christoph; Zehner, Matthias; Weber, Timm; Ercanoglu, Meryem S.; Gieselmann, Lutz; Rohde, Cornelius; Halwe, Sandro; Korenkov, Michael; Schommers, Philipp; Vanshylla, Kanika; Di Cristanziano, Veronica; Janicki, Hanna; Brinker, Reinhild; Ashurov, Artem; Kraehling, Verena; Kupke, Alexandra; Cohen-Dvashi, Hadas; Koch, Manuel; Eckert, Jan Mathis; Lederer, Simone; Pfeifer, Nico; Wolf, Timo; Vehreschild, Maria J. G. T.; Wendtner, Clemens; Diskin, Ron; Gruell, Henning; Becker, Stephan und Klein, Florian
(2020):
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
In: Cell, Bd. 182, Nr. 4: S. 843-854
Koch, Till; Dahlke, Christine; Fathi, Anahita; Kupke, Alexandra; Kraehling, Verena; Okba, Nisreen M. A.; Halwe, Sandro; Rohde, Cornelius; Eickmann, Markus; Volz, Asisa; Hesterkamp, Thomas; Jambrecina, Alen; Borregaard, Saskia; Ly, My L.; Zinser, Madeleine E.; Bartels, Etienne; Poetsch, Joseph S. H.; Neumann, Reza; Fux, Robert; Schmiedel, Stefan; Lohse, Ansgar W.; Haagmans, Bart L.; Sutter, Gerd; Becker, Stephan und Addo, Marylyn M.
(2020):
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial.
In: Lancet Infectious Diseases, Bd. 20, Nr. 7: S. 827-838